Variation in Brucella abortus 2308 infection in BALB/c mice induced by prior vaccination with salt-extractable periplasmic proteins from Brucella abortus 19

Infection and Immunity

Volumn 64, Issue 2, 1996, Pages 548-556

  Pugh Jr , George W ^a   Tabatabai, Louisa B ^a  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM SULFATE; ANTIBODY; ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; PHOSPHORYL LIPID A; PROTEIN; VACCINE; VIRULENCE FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRUCELLA ABORTUS; BRUCELLOSIS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOGENICITY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; SPLEEN SIZE; VACCINATION; VIRULENCE;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; BRUCELLA ABORTUS; BRUCELLOSIS; FEMALE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPID A; MICE; MICE, INBRED BALB C; ORGAN SIZE; SPLEEN; VACCINATION;

EID: 0030061539     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.2.548-556.1996     Document Type: Article

References (60)

1. Araya, L. N., P. H. Elzer, G. E. Rowe, F. M. Enright, and A. J. Winter. 1989. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus J. Immunol. 143:3330-3337
2. Bascoul, S., M. Cannat, M. Huguet, and A. Serre. 1978. Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum. Immunology 35:213-221.
3. Beauclair, K. D., and D. N. Khansari. 1990 Protection of mice against Brucella abortus by immunization with polyclonal anti-idiotype antibodies. Immunobiology 180:208-220.
4. Beck, B. L., L. B. Tabatabal, and J. E. Mayfield. 1990. A protein isolated from Brucella abortus is a Cu-Zn Superoxide dismutase. Biochemistry 29:372-376.
5. Belzer, C. A., L. B. Tabatabai, and B. L. Deyoe. 1991. Differentiation by Western blotting of immune responses of cattle vaccinated with Brucella abortus strain 19 or infected experimentally or naturally with virulent Brucella abortus. Vet. Microbiol. 27:79-90
6. Bosseray, N. 1978 Immunity to Brucella in mice vaccinated with a fraction (F8) or a killed vaccine (H38) with or without adjuvant, level and duration of immunity in relation to dose of vaccine, recall injection, and age of mice. Br. J. Exp. Pathol. 59:354-365.
7. Bricker, B. J., L. B. Tabatabai, B. L. Deyoe, and J. E. Mayfield. 1988 Conservation of antigenicity in a 31-KDa Brucella protein. Vet. Microbiol. 18:313-325.
8. Cheers, C. 1984. Pathogenesis and cellular immunity in experimental murine brucellosis Dev. Biol. Stand 56:237-246.
9. Cheers, C., and A. M. Young. 1987. Serum colony stimulating activity and colony forming cells in murine brucellosis relationship to immunopathology. Microb. Pathog. 3:185-194.
10. Cherwonogrodzky, J. W., G. Dubray, E. Morena, and H. Mayer. 1990. Antigens of Brucella, p. 19-64. In K. Nielsen and J. R Duncan (ed.). Animal brucellosis. CRC Press, Inc., Boca Raton, Fla.
11. Corbeil, L. B., G. G. Schurig, P. J. Bier, and A. J. Winter. 1975. Bovine venereal vibriosis: antigenic variation of the bacterium during infection. Infect. Immun. 11:240-244.
12. Dubray, G. 1987 Protective antigens in brucellosis. Ann Inst Pasteur/Microbiol (Paris) 138:84-87.
13. Ellwood, D. C. 1975 Variation of cell surfaces in relation to pathogenicity. Proc. Soc Gen Microbiol. 3:72-83.
14. Ellwood, D. C., J. Keppie, and H. Smith. 1967. The chemical basis of the virulence of Brucella abortus. VIII. The identity of purified immunogenic material from culture filtrate and the cell-wall of Brucella abortus grown in vitro Br. J. Exp. Pathol. 48:28-39.
15. Elzer, P. H., R. H. Jacobson, S. M. Jones, K. H. Nielsen, J. T. Douglas, and A. J. Winter. 1994 Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19. Immunology 82:651-658
16. Enright, F. M. 1990. Mechanisms of self cure in Brucella abortus infected cattle. p 191-196. In L G. Adams (ed.), Advances in brucellosis research. Texas A&M University Press, College Station.
17. Frenchick, P. J., R. J. F. Markham, and A. H. Cochrane. 1985. Inhibition of phagosome-lysosome fusion in macrophages by soluble extracts of virulent Brucella abortus. Am. J. Vet Res. 46:332-335.
18. Goodenough, U. W. 1991. Deception by pathogens: viruses and bacteria do not always mount a frontal attack on the body; many of them have evolved tactics of camouflage, distraction and mimicry. Am. Sci. 79:344-355.
19. Griffiths, E. 1991. Environmental regulation of bacterial virulence - implications for vaccine design and production Trends Bictechnol 9:309-315.
20. Halling, S. M., P. G. Detilleux, F. M. Tatum, B. A. Judge, and J. E. Mayfield. 1991. Deletion of the BCSP31 gene of Brucella abortus by replacement. Infect. Immun. 59:3863-3868.
21. Henricson, B. E., W. R. Benjamin, and S. N. Vogel. 1990 Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance. Infect. Immun. 58:2429-2437
22. Hoffman, M. 1990. "Superantigens" may shed light on immune puzzle. Bacterial toxins may illuminate why the immune system responds to some antigens but not to others. Science 248:685-686.
23. Jacques, I., V. Olivier-Bernardin, and G. Dubray. 1991. Induction of antibody and protective responses in mice by Brucella a polysaccharide-BSA conjugate Vaccine 9:896-900.
24. Kurtz, R. S., and D. T. Berman. 1986. Influence of endotoxin-protein in immunoglobulin G isotype responses of mice to Brucella abortus lipopolysaccharide. Infect. Immun. 54:728-734.
25. Latimer, E., J. Simmer, N. Srianganathan, R. M. Roop II, G. G. Schurig, and S. M. Boyle. 1992. Brucella abortus deficient in copper/zinc Superoxide dismutase is virulent in BALB/c mice. Microb Pathog. 12:105-113.
26. Loeb, M. R., and H. D. Smith. 1980 Outer membrane protein composition in disease isolates of Haemophilus influenzae: pathogenic and epidemiological implications. Infect. Immun. 30:709-717.
27. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol Chem. 193:265-275
28. McCullough, N. B. 1970. Microbial and host factors in the pathogenesis of brucellosis, p. 324-345. In S. Mudd (ed.), Infectious agents and host reactions The W. B. Saunders Co., Philadelphia
29. Misfeldt, M. L. 1990. Minireview: microbial "Superantigens" Infect. Immun. 58:2409-2413.
30. Moreno, E., R. S. Kurtz, and D. T. Berman. 1984. Induction of immune and adjuvant immunoglobulin G responses in mice by Brucella lipopolysaccharide Infect Immun. 46:74-80.
31. Pardon, P. 1977. Resistance against a subcutaneous Brucella challenge in mice immunized with living and dead Brucella or by transfer of immune serum. Ann. Immunol. (Paris) 128C:1025-1037.
32. Phillips, M., B. L. Deyoe, and P. C. Canning. 1989. Protection of mice against Brucella abortus infection by inoculation with monoclonal antibodies recognizing Brucella O-antigen. Am J. Vet Res. 50:2158-2161.
33. Phillips, M., G. W. Pugh, Jr., and B. L. Deyoe. 1989. Chemical and protective properties of Brucella lipopolysaccharide obtained by butanol extraction. Am. J. Vet. Res. 50:311-317.
34. Phillips, M., G. W. Pugh, Jr., and B. L. Deyoe. 1989. Duration of strain 2308 infection and immunogenicity of Brucella abortus lipopolysaccharide in 5 strains of mice. Am. J. Vet. Res. 50:318-322
35. Plommet, M., and A. M. Plommet. 1987. Anti-Brucella cell-mediated immunity in mice vaccinated with a cell wall fraction. Ann. Inst. Vet. 18:429-437.
36. Pugh, G. W., Jr., M. Phillips, L. B. Tabatabai, and T. J. McDonald. 1991. Unresponsiveness of vaccinated BALB/c mice to a second inoculation of lipopolysaccharide from Brucella abortus strain 2308 Vet. Microbiol. 26:167-177.
37. Pugh, G. W., Jr., and L. B. Tabatabai. 1994. Alteration of protective and serological responses in BALB/c mice vaccinated with chemically modified versus nonmodified proteins of Brucella abortus 19 Infect. Immun. 62:5327-5334.
38. Pugh, G. W., Jr., L. B. Tabatabai, B. J. Bricker, J. E. Mayfield, M. Phillips, T. J. McDonald, and E. S. Zehr. 1989. Identification of a virulence factor for Brucella abortus infection in BALB/c mice. Am. J. Vet. Res. 50:887-892
39. Pugh, G. W., Jr., L. B. Tabatabai, B. J. Bricker, J. E. Mayfield, M. Phillips, E. S. Zehr, and C. A. Belzer. 1990. Immunogenicity of Brucella-extracted and recombinant protein vaccines in CD-1 and BALB/c mice. Am. J. Vet. Res 51:1413-1420
40. Pugh, G. W., Jr., L. B. Tabatabai, M. Phillips, and T. J. McDonald. 1991 Establishment of dose-response relationships in BALB/c mice using Brucella cell surface protein and lipopolysaccharide. Am. J. Vet. Res. 52:261-268.
41. Pugh, G. W., Jr., E. S. Zehr, V. P. Meador, M. Phillips, T. J. McDonald, and B. L. Deyoe. 1989 Immunologic, histopathologic, and bacteriologic responses of 5 strains of mice to Brucella abortus strain 2308. Am. J. Vet. Res 50:323-328.
42. Schwab, J. B. 1975. Suppression of the immune response by microorganisms Bacteriol. Rev. 39:121-143.
43. Smith, R., III, L. G. Adams, B. A. Sowa, and T. A. Ficht. 1990. Induction of lymphocyte responsiveness by the outer membrane-peptidoglycan complex of rough strains of Brucella abortus. Vet Immunol. Immunopathol. 26:31-48.
44. Sriranganathan, N., S. M. Boyle, G. G. Schurig, and H. Misra. 1991 Superoxide dismutase of virulent and avirulent strains of Brucella abortus. Vet Microbiol. 26:359-366.
45. Stabel, T. J., J. E. Mayfield, L. B. Tabalabai, and M. J. Wannemuebler. 1990 Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus Infect. Immun. 58:2048-2055.
46. Stabel, T. J., Z. Sha, and J. E. Mayfield. 1994. Periplasmic location of Brucella abortus Cu/Zn Superoxide dismutase. Vet Microbiol. 38:307-314
47. Stevens, M. G., S. C. Olsen, G. W. Pugh, Jr., and D. Brees. 1995. Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51. Infect. Immun. 63:264-270.
48. Stevens, M. G., S. C. Olsen, G. W. Pugh, Jr., and M. V. Palmer. 1994 Immune and pathologic responses in mice infected with Brucella abortus 19. RB51, or 2308. Infect. Immun 62:3206-3212.
49. Stevens, M. G., L. B. Tabatabai, S. C. Olsen, and N. F. Cheville. 1994 Immune responses to Superoxide dismutase and synthetic peptides of superoxide dismutase in cattle vaccinated with Brucella abortus strains 19 and RB51. Vet, Microbiol. 41:383-389.
50. Tabatabai, L. B., and B. L. Deyoe. 1984. Specific enzyme-linked immunosorbent assay for detection of bovine antibody to Brucella abortus. J. Clin Microbiol. 20:209-213.
51. Tabatabai, L. B., B. L. Deyoe, and J. M. Patterson. 1989. Immunogenicity of Brucella abortus salt-extractable proteins. Vet Microbiol 20:49-58.
52. Tabatabai, L. B., B. L. Deyoe, and A. E. Ritchie. 1979. Isolation and characterization of toxic fractions from Brucella abortus. Infect. Immun. 26:668-679
53. Tabatabai, L. B., and G. W. Pugh, Jr. 1994. Modulation of immune responses in BALB/c mice vaccinated with Brucella abortus Cu-Zn Superoxide dismutase synthetic peptide vaccine. Vaccine 12:919-924.
54. Tabatabai, L. B., G. W. Pugh, Jr., M. G. Stevens, and M. Phillips. 1992. Monophosphoryl lipid A-induced immune enhancement of Brucella abortus salt-extractable protein and lipopolysaccharide vaccines in BALB/c mice Am. J. Vet. Res. 53:1900-1907.
55. Tam, J. P. 1988 Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci USA 85:5409-5413
56. Tam, J. P., P. Clavijo, Y. A. Lu, V. Nussenzweig, R. Nussenzweig, and F. Zafala. 1990. Incorporation of T and B cell epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J. Exp. Med. 171:299-306.
57. Tatum, F. M., P. G. Detilleux, J. M. Sacks, and S. M. Hailing. 1992 Construction of Cu-Zn Superoxide dismutase deletion mutants of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in mice. Infect. Immun 60:2863-2869.
58. Voller, A., and D. E. Bidwell. 1975. A simple method for detecting antibodies to rubella. Br. J Exp Pathol. 56:338-339.
59. Winter, A. J. 1987. Outer membrane proteins of Brucella. Ann. Inst. Pasteur/ Microbiol. (Paris) 138:87-89.
60. Winter, A. J., and G. E. Rowe. 1988. Comparative immune responses to native cell envelope antigens and the hot sodium dodecyl insoluble fraction (PG) of Brucella abortus in cattle and mice. Vet. Immunol Immunopathol. 18:149-163.